The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: Possible contribution to elevated plasma levels of soluble TNF alpha receptors
- 31 July 2006
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 187 (1), 82-91
- https://doi.org/10.1016/j.atherosclerosis.2005.08.031
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Proinflammatory properties of murine aortic endothelial cells exclusively expressing a non cleavable form of TNFαThrombosis and Haemostasis, 2004
- Increased mRNA expression of tumour necrosis factor-α and its converting enzyme in circulating leucocytes of patients with acute myocardial infarctionClinical Science, 2003
- Effect of anti-tumor necrosis factor-α polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic modelAtherosclerosis, 2002
- Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFα confers no additional benefitAtherosclerosis, 2001
- Accumulation of LDL in Rat Arteries Is Associated With Activation of Tumor Necrosis Factor-α ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting EnzymeJournal of Biological Chemistry, 2000
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- The potential biological and clinical significance of the soluble tumor necrosis factor receptorsCytokine & Growth Factor Reviews, 1996
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990